Details for Patent: 5,149,693
✉ Email this page to a colleague
Summary for Patent: 5,149,693
Title: | Combination of tobramycin and fluorometholone for topical ophthalmic use |
Abstract: | Disclosed are pharmaceutical compositions comprising tobramycin and fluorometholone or fluorometholone acetate for topical ophthalmic delivery and methods of treatment comprising administering said composition when indicated for infection and control of inflammatory response for optimal wound healing and normalization of the eye. |
Inventor(s): | Cagle; Gerald D. (Fort Worth, TX), McDonald; Thomas O. (Fort Worth, TX), Rosenthal; Allan L. (Fort Worth, TX) |
Assignee: | Alcon Laboratories, Inc. (Fort Worth, TX) |
Application Number: | 07/440,912 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; | More… ↓ |
Drugs Protected by US Patent 5,149,693
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,149,693
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 122564 | ⤷ Subscribe | |||
Australia | 3347689 | ⤷ Subscribe | |||
Australia | 606515 | ⤷ Subscribe | |||
Canada | 1338554 | ⤷ Subscribe | |||
Germany | 365613 | ⤷ Subscribe | |||
Germany | 68922688 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |